The present invention relates to primers and a method for detecting
related gene SNP (
single nucleotide polymorphism) sites of
metformin-individualized medications. The primers can detect a rs2289669SNP site of a SLC47A1
gene. The primer sequences comprise a wild-type upstream primer, a
mutant-type upstream primer and a shared downstream primer. Improvement is made on the basis of ARMS-PCR, a specific primer and the shared downstream primer are designed for SNP sequences, mismatched bases are introduced at a second position of a 3' end of the specific primerto widen a gap between amplification efficiency of
complementation and non-
complementation of the bases of the 3' end of the specific primer and SNP site bases on
a DNA template, thereby greatly improving specificity and accuracy of detection. A real-time PCR technology is introduced, identification can be made according to a [
delta]Ct value, that is, the [
delta]Ct value is equal to
mutant Ct-wild Ct. In general, when [
delta]Ct islarger than 7, the SNP site is a
wild type, when [delta]Ct is less than -7, the SNP site is a
mutant type, and when the [delta]Ct is larger than -2 and less than 2, the SNP site is a heterozygous type. Advantages are that the method is fast, simple, economical, accurate and reliable identification of results, and high in specificity.